Robert Turner Schooley MD

PubMed

• Knowledge, attitudes, and perception of dog owners on the transmission, control and prevention of cystic echinococcosis and other gastrointestinal parasites in dogs of...
  Regina D Miambo, Sonia M de S Afonso, Emilia V Noormahomed, Claudia Tamponi, Antonio Varcasia
  BMC Veterinary Research. 2025-03-19
• 1 citations
  resensitization of multidrug-resistant clinical isolates ofandthrough phage-antibiotic synergy.
  Pooja Ghatbale, Govind Prasad Sah, Sage Dunham, Ethan Khong, Alisha Blanc
  Antimicrobial Agents and Chemotherapy. 2025-02-13
• Distributed cross-learning for equitable federated models - privacy-preserving prediction on data from five California hospitals.
  Tsung-Ting Kuo, Rodney A Gabriel, Jejo Koola, Robert T Schooley, Lucila Ohno-Machado
  Nature Communications. 2025-02-05

Journal Articles

• Successful Treatment of Antibiotic Resistant Poly-Microbial Bone Infection with Bacteriophages and Antibiotics Combination  
  Robert Schooley, MD, Clinical Infectious Diseases
• Oa the Evolution of Mentorship Capacity Development in Low- and Middle-Income Countries: Case Studies from Peru, Kenya, India, and Mozambique  
  Robert Schooley, MD, The American Journal of Tropical Medicine and Hygiene
• The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical Studies  
  Elizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases
• Herd Immunity Likely Protected the Men Who Have Sex with Men in Recent Hepatitis A Outbreak in San Diego CA  
  Robert Schooley, MD, Clinical Infectious Diseases
• Effects of cycloheximide on the response of intestinal mucosa to cholera enterotoxin.  
  Kimberg DV, Field M, Gershon E, Schooley RT and Henderson A, J Clin Invest. 1973; 52:1376-83
• Edema associated with ibuprofen therapy.  
  Schooley RT, Wagley PF and Lietrnan PS, JAMA. 1977; 237:1716-7
• Adult-onset acid maltase deficiency. Case report of an adult with severe respiratory difficulty.  
  Lightman NI and Schooley RT, Chest. 1977; 72:250-2
• Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis.  
  Haynes BF, Schooley RT, Grouse JE, Payling-Wright CR, Dolin R and Fauci AS, J Immunol. 1979; 122:699-702
• Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis.  
  Haynes BF, Schooley RT, Payling-Wright CR, Grouse J, Dolin R and Fauci AS, J Immunol. 1979; 123:2095-101
• Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation.  
  Schooley RT, Haynes BF, Payling-Wright CR, Grouse J, Dolin R and Fauci AS, Cellular Immunol. 1980; 56:518-25
• Facial erysipelas in the immunocompromised host. Report of two cases.  
  Cupps TR, Cotton DJ, Schooley RT and Fauci AS, Arch Dermatol. 1981; 117:47-9
• Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia.  
  Wasson DL, Loegering DA, Solley GO, Moore SB, Schooley RT, Fauci AS and Gleich GJ, J Clin lnvest. 1981; 67:651-61
• A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations.  
  Flaum MA, Schooley RT, Fauci AS and Gralnick HR, Blood. 1981; 58:1012-20
• A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations.  
  Schooley RT, Flaum MA, Gralnick HR and Fauci AS, Blood. 1981; 58:1021-6
• Development of suppressor T-lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: Assessment by two quantitative sys...  
  Schooley RT, Haynes BF, Grouse J, Payling-Wright CR, Fauci AS and Dolin R, Blood. 1981; 57:510-7
• The effect of infection of T-lymphocyte subpopulations: a preliminary report.  
  Rubin RH, Carney WP, Schooley RT, Colvin RB, Burton RC, Hoffman RA, Hansen WP, Cosimi AB, Russell PS and Hirsch MS, Int J lmmunopharmacol. 1981; 3:307-12
• Detection by immune electron microscopy of Snow Mountain agent of acute viral gastroenteritis.  
  Dolin R, Reichman RC, Roessner KD, Tralka TS, Schooley RT, Gary W and Morens D, J Inf Dis. 1982; 146:184-9
• Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.  
  Thorley-Lawson DA, Schooley RT, Bhan AK and Nadler LM, Cell. 1982; 30:415-25
• Mass mortality of harbor seals: pneumonia associated with influenza A virus.  
  Geraci JR, St. Austin DJ, Barker, IK, Webster RG, Hinshaw VS, Bean WJ, Ruhnke HL, Prescott JH, Early G, Baker AS, Madoff S and Schooley RT, Science. 1982; 215:1129-31
• Monoclonal antibody against EBV-associated transformation antigen detected in vitro and in vivo.  
  Thorley-Lawson DA, Geilinger K and Schooley RT, Protides Biol Fluid Colloq. 1982; 29:739-42
• Serological responses and systemic reactions in adults with monovalent A/USSR/77 and trivalent A/USSR/77-A/Texas/77-B/Hong Kong/72 influenza vaccine.  
  Quinnan GV, Schooley RT, Dolin R, Ennis FA, Gross P and Gwaltney JM, Rev Infect Dis. 1983; 5:748-57
• Two-dimensional echocardiographic assessment of the idiopathic hyper-eosinophilic syndrome. Anatomic basis of rnitral regurgitation and peripheral embolization.  
  Gottdiener JS, Maron BJ, Schooley RT, Harley JB, Roberts WC and Fauci AS, Circulation. 1983; 67:572-8
• Analysis of cellular immune response to EBV by using cloned T cell lines.  
  Slovin SF, Schooley RT and Thorley-Lawson DA, J Immunol. 1983; 130:2127-32
• Association of herpes virus infections with T-lymphocyte subset alterations, glomerulopathy, and opportunistic infections following renal transplantation.  
  Schooley RT, Hirsch MS, Colvin R.B, Cosimi AB, Tolkoff-Rubin NE, McCluskey RT, Burton RC, Russell PS, Herrin JT, Delmonico FL, Giorgi JV, Henle W and Rubin RH, N Engl J Med. 1983; 308:307-13
• Phenotypic analysis of New World primate mononuclear cell surface antigens.  
  Schooley RT, Byington R and Falk Jr. LA, J Med Primatology. 1983; 12:30-40
• Join now to see all

Books/Book Chapters

• Current Clinical Topics in Infectious Diseases. 
  Chapter: Chronic Fatique Syndrome: A Manifestation of Epstein-Barr Virus Infection? 
  Page 126 - 146Schooley RTEditors: JS Remington and MN Swartz.McGraw-Hill Book Co
• Host Responses to Infections in Infectious Diseases. 
  Page 30 - 44Wilson CC and Schooley RTMosby Elsevier, LondonEdition 3,
• Cecil’s Textbook of Internal Medicine. 
  Chapter: Epstein Barr Virus Infection 
  Schooley RT
• Mechanisms of Microbial Diseases. 
  Chapter: Human Retroviruses: AIDS and Other Diseases 
  Page 376 - 388Schooley RTEditors: Engleberg NC, DiRita V and Dermody TS.Lippincott Williams and WilkinsEdition 4,
• AIDS and Other Manifestations of HIV Infection. 
  Chapter: Antiretroviral Chemotherapy 
  Page 827 - 840Schooley RTEditors: G.P. Wormser.Raven Press, New YorkEdition 4,
• Principles and Practice of Infectious Diseases. 
  Chapter: Epstein-Barr Virus (Infectious Mononucleosis) 
  Schooley RT and Dolin RJohn Wiley and Sons, New YorkEdition 4,
• Principles and Practice of Infectious Diseases. 
  Chapter: Chronic Fatigue Syndrome 
  Schooley RTJohn Wiley and Sons, New YorkEdition 4,
• Textbook of AIDS Medicine. 
  Chapter: Immune Based Therapies for HIV-1 Infection 
  Page 713 - 720Schooley RTEditors: S. Broder, D.P. Bolognesi and T.C. Merigan, Jr.Williams and Wilkins, Baltimore
• HIV Molecular Organization, Pathogenicity and Treatment. 
  Chapter: HIV-1 Specific Immune Responses 
  Page 75 - 98Connick E and Schooley RTEditors: W.J.W. Morrow and N. Haigwood.Elsevier Science Publishers, The Netherlands
• AIDS and Other Manifestations of HIV Infection. 
  Chapter: Antiretroviral Chemotherapy 
  Page 609 - 623Schooley RTEditors: G.P. Wormser.Raven Press, New York
• AIDS: Etiology, Diagnosis, Treatment, and Prevention. 
  Chapter: Herpesvirus Infection in Individuals with HIV Infection 
  Page 193 - 207Schooley RTEditors: V.T. DeVita, S. Hellman and S.A. Rosenberg, J.B.Lippincott Company, PhiladelphiaEdition 3,
• Neurological and Neurosurgical Intensive Care. 
  Chapter: Encephalitis 
  Page 411 - 435Schooley RTEditors: A.H. Ropper.Raven Press, New YorkEdition 3,
• Respiratory Disease in the Immunosuppressed Host. 
  Chapter: Pneumonia Due to Herpesviruses 
  Page 386 - 397Schooley RTEditors: J Shelhamer, et al.Lippincott Company, Philadelphia
• Merck Manual of Diagnosis and Theapy. 
  Chapter: Infectious Mononucleosis 
  Schooley RTMerck Sharp & Dohme Research Laboratories, Rahway, NJEdition 15,
• Principles and Practice of Infectious Diseases. 
  Chapter: Epstein-Barr Virus (Infectious Mononucleosis) 
  Page 1172 - 1185Schooley RT and Dolin RJohn Wiley and Sons, New YorkEdition 3,
• Clinical Approach to Infection in the Compromised Host. 
  Chapter: Morbidity in Compromised Patients Due to Viruses Other Than Herpes Group and Hepatitis Viruses 
  Schooley RTEditors: RH Rubin and LS Young.Plenum Book Company, New York and LondonEdition 2,
• Principles and Practice of Infectious Diseases. 
  Chapter: Epstein-Barr Virus (Infectious Mononucleosis) 
  Page 1324 - 1341Schooley RT and Dolin RJohn Wiley and Sons, New York
• HIV and Other Highly Pathogenic Viruses. 
  Chapter: Interferon Alpha in the Therapy of Patients with HW Infections 
  Page 113 - 124Schooley RTAcademic Press Inc, Roberts A. Smith
• Perspectives for lymphokine therapy: from genetic engineering to immunologic engineering. 
  Page 131 - 42Schooley RTEditors: C. Th. Smit Sibinga, P.D. Das, C. P. Engelfriet.Nijhoff Publishing
• Infections in Transplant Patients. 
  Chapter: Prophylactic and Therapeutic perspective in viral infections 
  Page 205 - 224Schooley RTGeorg Thieme Verlag Stuttgart
• Neurological and Neurosurgical Intensive Care. 
  Chapter: Encephalitis 
  Page 289 - 307Schooley RTEditors: A. H. Ropper and S. F. Kennedy.Aspen Publication, Rockville, MarylandEdition 2,
• Primary Care Medicine. 
  Chapter: AIDS 
  Page 637 - 641Schooley RTEditors: AM Gorell, LA May, AG Mulley.Lippincott, PhiladelphiaEdition 2,
• Harrison's Textbook of Internal Medicine. 
  Chapter: Epstein Barr virus infections, including mononucleosis 
  Page 699 - 703Schooley RTMcGraw-Hill, New YorkEdition 11,
• The Biology of the Interferon System. 
  Chapter: Interferon trials in immunocompromised patients 
  Hirsch MS and Schooley RTEditors: Kirchner H and Schellekens H.Elsevier, Amsterdam
• Principles and Practice of Infectious Diseases. 
  Chapter: Epstein-Barr Virus (Infectious Mononucleosis) 
  Page 971 - 982Schooley RT and Dolin RJohn Wiley and Sons, New YorkEdition 2,
• Join now to see all

Abstracts/Posters

• Long-term propagation of New World primate T-lymphocytes in vitro.
  Falk Jr. LA, Silva D, Byington R and Schooley RT, Fifteenth International Leukocyte Culture Conference. Intercell Communicat in Leucocyte Function

Other

• Just (Don't) Do It. 
  Schooley RT, J Clin Invest. 1993; 92:535
• Hepatitis C virus therapeutics: at the end of the beginning. 
  Schooley RT, Top Antivir Med. 2012; 20:17-9
• Viral Load Testing in Resource Limited Settings. 
  Schooley RT, Clin Infect Dis. 2007; 44: 139-40
• Starting highly active antiretroviral therapy for HIV infection: is it WIHS to wait? 
  Schooley RT, Ann Intern Med. 2004;140:305-6
• Longer-term immunologic effects and side effects of successful antiretroviral therapy. 
  Schooley, RT, Clin Infect Dis. 1999; 29:12-8
• Antiretroviral chemotherapy. 
  Saag MS and Schooley RT, Curr Clin Top Infect Dis. 1998; 18:154- 79
• Check, but not checkmate. 
  Schooley RT, Antiviral Therapy. 1997; 2:68-9
• Therapeutic decision making in 1997. 
  Cotton D, Bartlett J, Schooley R, Gulick R
• Enhancing HIV-1 Specific Immunity as a Therapeutic Strategy in AIDS. 
  Schooley RT, Advances in Exper Med and Biol. 1996; 394:405-10
• Immunomodulatory effects of antiretroviral chemotherapy. 
  Schooley RT, J Biol Regul Homeost Agents. 1995; 9:110-3
• HIV-1 specific cytotoxic T-cell responses. 
  Schooley RT, AIDS. 1995; 9:S113-6
• Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. 
  Schooley RT, AIDS. 1995; 9:S15-9
• Epstein-Barr Virus: Current Concepts. 
  Schooley RT and Hirsch MS, Infect Disease Practice.1980; 3:1-7
• Challenges in the clinical development of antiretroviral drugs. 
  Schooley RT, Antiviral Research. 1992; 17:305-10
• Cytomegalovirus in the setting of infection with human immunodeficiency virus. 
  Schooley RT, Rev Infect Dis. 1990; 12:S811-9
• Epstein-Barr virus. 
  Schooley RT, Current Opinion in Infectious Diseases. 1989; 2:267-71
• Waltzing HIV-tilda (editorial). 
  Schooley RT, Arch Intern Med. 1988; 148(4):778
• AIDS: Clinical Aspects and Biologic Therapies. 
  Schooley RT, Immunology and Allergy Clinics. 1988; 93-109
• Chemotherapie und immunoprophylaxe der HIV-infektion. 
  Vogt M, Schooley RT and Hirsch MS, Schweizerische Rndschau fur Medizin Praxis. 1986; 75:1471-5
• An overview of antiviral therapy of HTLV-III/LAV infection. 
  Vogt MW and Schooley RT, Noyes Publications
• Are apheresis personnel at risk for AIDS Plasma Therapy & Transfusion Technology. 
  Vogt MW, Addison R, Schooley RT and Hirsch MS
• Lymphocyte markers and infectious diseases. 
  Blumberg RS and Schooley RT, Seminars in Hematology. 1985; 22:81-114
• How to manage infectious mononucleosis. 
  Schooley RT, Drug Therapy. December, 1983; 13:68-77
• Susceptibility to Acquired Immune Deficiency Syndrome (AIDS): Clinical Practice Update. 
  Schooley RT, Volume 2, Number 4
• Join now to see all